Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors
{{output}}
Btk is a tyrosine kinase dysregulated in several B-cell malignancies and autoimmune diseases, and this has given rise to a search for Btk inhibitors. Nevertheless, only one Btk inhibitor, ibrutinib, has been approved to date, although other compounds are curre... ...
